july NUMBER NUMBER patients irradiated heavy charged particles lawrence berkeley laboratory phase clinical trial study usefulness particles irradiation human cancers particles utilized included helium primarily improved dose distributions reduction dose adjacent normal tissues heavier particles carbon neon argon ions additional potential increased biologic effectiveness tumor especially hypoxic tumor cells initial results helium particles sufficiently good warrant phase iii randomized trial carcinoma pancreas tumor sites particles phase phase ii studies progress short control irradiated area heterogeneous group patients appears good current megavoltage irradiation complications date acceptably low warranting studies heavy charged particles ii follow